Description

Prednisone Acetate is a synthetic glucocorticoid widely used in research to explore anti-inflammatory, immunosuppressive, and metabolic pathways. It suppresses inflammatory cytokines and modulates immune cell activity in both cellular and animal models.

These tablets are manufactured by Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., under approval number H31020771. Supplied as 100 × 5?mg tablets per bottle, this formulation is intended strictly for experimental research and not for clinical or human use.

Product Specifications

Mechanism of Action & Research Applications

Prednisone Acetate is converted in vivo to prednisolone, which binds to glucocorticoid receptors to regulate gene expression involved in inflammation and immune response. In research, Prednisone Acetate Tablets (Tianyi) are used to investigate:

• Cytokine suppression and inflammatory cascade modulation

• Immunosuppression in autoimmune and transplant models

• Hormonal regulation of metabolism and stress response

• Signaling pathways mediated by glucocorticoid receptor activation

These tablets offer a stable and standardized dosage for laboratory research in immunology, physiology, and pharmacology.

Side Effects (For Reference Only in Models)

In controlled experimental models, Prednisone Acetate Tablets (Tianyi) may produce:

• Suppression of immune cell activation

• Altered glucose metabolism or insulin sensitivity

• Weight gain or muscle wasting in prolonged dosing

• Bone metabolism changes in long-term protocols

These observations are context-specific to research settings and do not reflect clinical safety profiles.

Disclaimer

Prednisone Acetate Tablets (Tianyi) are strictly for laboratory and experimental research use only. They are not approved for human or veterinary therapeutic use. Research should be conducted under institutional and regulatory safety protocols.